Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV- 2-based lentivirus vectors

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6527-6536

  Poeschla, Eric ^a   Gilbert, James ^a   Li, Xinqiang ^a   Huang, Shiang ^a   Ho, Anthony ^a   Wong Staal, Flossie ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; VIRUS VECTOR;

ARTICLE; GENE DELETION; GENETIC TRANSDUCTION; HELA CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CAPSID; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0031903410     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6527-6536.1998     Document Type: Article

References (66)

1. Agrawal, Y. P., R. S. Agrawal, A. M. Sinclair, D. Young, M. Maruyama, F. Levine, and A. D. Ho. 1996. Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells. Exp. Hematol. 24:738-747.
2. Baba, T. W., Y. S. Jeong, D. Pennick, R. Bronson, M. F. Greene, and R. M. Ruprecht. 1995. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267:1820-1826.
3. Bender, M. A., T. D. Palmer, R. E. Gelinas, and A. D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
4. Berkowitz, R. D., and S. P. Goff. 1994. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. Virology 202:233-246.
5. Berkowitz, R. D., M. L. Hammarskjold, C. Helga-Maria, D. Rekosh, and S. P. Goff. 1995. 5′ regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology 212:718-723.
6. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
7. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
8. Carroll, R., J.-T. Lin, E. J. Dacquel, J. D. Mosca, D. S. Burke, and D. C. St. Louis. 1994. A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J. Virol. 68:6047-6051.
9. Chatterjee, P., A. Garzino-Demo, P. Swinney, and S. K. Arya. 1993. Human immunodeficiency virus type 2 multiply spliced transcripts. AIDS Res. Hum. Retroviruses 9:331-335.
10. Clever, J., C. Sassetti, and T. G. Parslow. 1995. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:2101-2109.
11. Coffin, J. M. 1992. Retroviral DNA integration. Dev. Biol. Stand. 76:141-151.
12. Colombini, S., S. K. Arya, M. S. Reitz, L. Jagodzinski, B. Beaver, and F. Wong-Staal. 1989. Structure of simian immunodeficiency virus regulatory genes. Proc. Natl. Acad. Sci. USA 86:4813-4817.
13. Cook, D. G., M. S. Forman, J. C. Sung, S. Leight, D. L. Kolson, T. Iwatsubo, V. M. Y. Lee, and R. W. Doms. 1997. Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3:1021-1023.
14. Cook, D. G., V. M. Lee, and R. W. Doms. 1994. Expression of foreign proteins in a human neuronal system. Methods Cell Biol. 43(Part A):289-303.
15. Corbeau, P., G. Kraus, and F. Wong-Staal. 1996. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc. Natl. Acad. Sci. USA 93:14070-14075.
16. Emerman, M. 1996. From curse to cure: HIV for gene therapy? Nat. Biotechnol. 14:943.
17. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
18. Gallay, P., S. Swingler, J. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83:569-576.
19. Garzino-Demo, A., R. C. Gallo, and S. K. Arya. 1995. Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. Hum. Gene Ther. 6:177-184.
20. Geigenmuller, U., and M. L. Linial. 1996. Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5′ HIV-1 genomic RNA sequence. J. Virol. 70:667-671.
21. Heim, R., A. B. Cubitt, and R. Y. Tsien. 1995. Improved green fluorescence. Nature 373:663-664. (Letter.)
22. Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
23. Holyoake, T. L., and M. J. Alcorn. 1994. CD34+ positive haemopoietic cells: biology and clinical applications. Blood Rev. 8:113-124.
24. Huberman, J. A. 1981. New views of the biochemistry of eucaryotic DNA replication revealed by aphidicolin, an unusual inhibitor of DNA polymerase alpha. Cell 23:647-648.
25. Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
26. Kanki, P. J., K. U. Travers, S. Mboup, C. C. Hsieh, R. G. Marlink, N. A. Gueye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, et al. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343:943-946.
27. Kim, H. J., K. Lee, and J. J. O'Rear. 1994. A short sequence upstream of the 5′ major splice site is important for encapsidation of HIV-1 genomic RNA. Virology 198:336-340.
28. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:2232-2239.
29. Kleppner, S. R., K. A. Robinson, J. Q. Trojanowski, and V. M. Lee. 1995. Transplanted human neurons derived from a teratocarcinoma cell line (NTera-2) mature, integrate, and survive for over 1 year in the nude mouse brain. J. Comp. Neurol. 357:618-632.
30. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1137-1151.
31. Lane, T. A., P. Law, M. Maruyama, D. Young, J. Burgess, M. Mullen, M. Mealiffe, L. W. Terstappen, A. Hardwick, M. Moubayed, et al. 1995. Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85:275-282.
32. Lansdorp, P. M., and W. Dragowska. 1993. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Exp. Hematol. 21:1321-1327.
33. Larochelle, A., J. Vormoor, H. Hanenberg, J. C. Wang, M. Bhatia, T. Lapidot, T. Moritz, B. Murdoch, X. L. Xiao, I. Kato, D. A. Williams, and J. E. Dick. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2:1329-1337.
34. Lever, A., H. Gottlinger, W. Haseltine, and J. Sodroski. 1989. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:4085-4087.
35. Lever, A. M. L. 1996. HIV and other lentivirus-based vectors. Gene Ther. 3:470-471.
36. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-576.
37. Linial, M. L., and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications. Curr. Top. Microbiol. Immunol. 157:125-152.
38. Looney, D. J., J. McClure, S. Kent, A. Radaelli, G. Kraus, A. Schmidt, K. Steffy, P. D. Greenberg, S. Hu, W. R. Morton, and F. Wong-Slaal. 1998. A minimally replicative HIV-2 live-virus vaccine protects M. nemestrina from disease after HIV-2287 challenge. Virology 242:150-160.
39. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C. C. Hsieh, M. C. Dia, E. H. Gueye, et al. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265:1587-1540.
40. McBride, M. S., and A. T. Panganiban. 1996. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. J. Virol. 70:2963-2973.
41. McCann, E. M., and A. M. Lever. 1947. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J. Virol. 71:4133-4137.
42. Miller, A. D. 1992. Retroviral vectors. Curr. Top. Microbiol. Immunol. 158:1-24.
43. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242. (Erratum, 12:443, 1992.)
44. Morrison, S. J., N. Uchida, and I. L. Weissman. 1995. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35-71.
45. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
46. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
47. Nienhuis, A. W. 1994. Gene transfer into hematopoietic stem cells. Blood Cells 20:141-147.
48. Pleasure, S. J., and V. M. Lee. 1993. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35:585-602.
49. Pleasure, S. J., C. Page, and V. M. Lee. 1992. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12:1802-1815.
50. Putkonen, P., L. Walther, Y. J. Zhang, S. L. Li, C. Nilsson, J. Albert, P. Biberfeld, R. Thorstensson, and G. Biberfeld. 1995. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1:914-918.
51. Rasmussen, R., P. Sharma, Y. Hu, and R. Ruprecht 1997. Presented at the 15th Annual Symposium on Non-Human Primate Models of AIDS, Seattle, Wash., Sept. 3 to 6.
52. Rizvi, T. A., and A. T. Panganiban. 1993. Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J. Virol. 67:2681-2688.
53. Saiki, R. K., T. L. Bugawan, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1986 Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324:163-166.
54. Srinivasakumar, N., N. Chazal, C. Helga-Maria, S. Prasad. M. L. Hammarskjold, and D. Rekosh. 1997. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J. Virol. 71:5841-5848.
55. Stevenson, M., B. Brichacek, N. Heinzinger, S. Swindells, S. Pirruccello, E. Janoff, and M. Emerman. 1995. Molecular basis of cell cycle dependent HIV-1 replication. Implications for control of virus burden. Adv. Exp. Med. Biol. 374:33-45.
56. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
57. Talbott, R., G. Kraus, D. Looney, and F. Wong-Staal. 1993. Mapping the determinants of human immunodeficiency virus 2 for infectivity, replication efficiency, and cytopathicity. Proc. Natl. Acad. Sci. USA 90:4226-4230.
58. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. J. Virol. 69:5659-5665.
59. Teare, G. F., P. K. Horan, S. E. Slezak, C. Smith, and J. B. Hay. 1991. Long-term tracking of lymphocytes in vivo: the migration of PKH-labeled lymphocytes. Cell. Immunol. 134:157-170.
60. Terstappen, L. W., S. Huang, M. Safford, P. M. Lansdorp, and M. R. Loken. 1991. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38-progenitor cells. Blood 77:1218-1227.
61. Unger, R. E., M. W. Stout, and P. A. Luciw. 1991. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA. Virology 182:177-185.
62. Vicenzi, E., D. S. Dimitrov, A. Engelman, T. S. Migone, D. F. Purcell, J. Leonard, G. Englund, and M. A. Martin. 1994. An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences. J. Virol. 68:7879-7890.
63. Viglianti, G. A., P. L. Sharma, and J. I. Mullins. 1990. Simian immunodeficiency virus displays complex patterns of RNA splicing. J. Virol. 64:4207-4216.
64. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
65. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.
66. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.